Blueprint Medicines Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BPMC Nasdaq 2834 www.blueprintmedicines.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Blueprint Medicines Corporation

Press Release: Sanofi completes acquisition of Blueprint Medicines - Jul 17th, 2025 11:00 pm
Press Release: Sanofi announces extension of Blueprint tender offer - Jul 16th, 2025 11:00 pm
High Growth Tech Stocks To Watch In The US July 2025 - Jul 14th, 2025 11:38 am
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. - Jul 14th, 2025 6:51 am
Exploring US High Growth Tech Stocks For Potential Opportunities - Jun 25th, 2025 11:38 am
Blueprint Medicines Presents Strong Long-Term Data for AYVAKIT in Systemic Mastocytosis - Jun 24th, 2025 10:45 am
Exploring 3 High Growth Tech Stocks In The US Market - Jun 23rd, 2025 11:38 am
Exploring Three High Growth Tech Stocks In The US Market - Jun 19th, 2025 11:38 am
Exploring High Growth Tech Opportunities in US Markets - Jun 17th, 2025 5:38 am
Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses - Jun 12th, 2025 4:01 pm
Why Is Acadia (ACAD) Up 26.1% Since Last Earnings Report? - Jun 6th, 2025 9:31 am
Why Blueprint Medicines Corporation (BPMC) Skyrocketed On Monday - Jun 3rd, 2025 12:22 am
These Stocks Are Moving the Most Today: Cleveland-Cliffs, Tesla, GM, Blueprint Medicines, BioNTech, DraftKings, and More - Jun 2nd, 2025 2:41 pm
Sanofi Just Spent $9.5 Billion on a Rare Disease You've Never Heard Of - Jun 2nd, 2025 11:39 am
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines - Jun 2nd, 2025 9:58 am
M&A is 'lifeblood' of biopharma: Analyst on Sanofi-Blueprint deal - Jun 2nd, 2025 9:45 am
Sanofi to acquire Blueprint Medicines, Boeing upgrade - Jun 2nd, 2025 9:43 am
Sanofi to expand immunology offerings with Blueprint Medicines - Jun 2nd, 2025 8:54 am
Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal. - Jun 2nd, 2025 7:50 am
Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio - Jun 2nd, 2025 7:40 am